𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of sulfametopyrazine (Kelfizine W) effects of a single oral dose

✍ Scribed by A. Devriendt; F. H. Jansen; I. Weemaes


Publisher
Springer
Year
1970
Tongue
English
Weight
693 KB
Volume
3
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Pharmacokinetics and safety of single or
✍ Dr. Irwin S. Morse πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 444 KB πŸ‘ 2 views

The pharmacokinetics of 100 mg, 200 mg, 400 mg, 600 mg, and 800 mg of lomefloxacin, a quinolone antimicrobial, were examined in a single sequential rising dose, placebocontrolled, crossover study. Each of 30 healthy male subjects (6 per group) received placebo and one dose of lomefloxacin, separated

Pharmacokinetics of tiaprofenic acid in
✍ L. Bertin; E. Rey; G. Pons; J. L. Mathiot; M. O. Richard; P. ChrΓ©tien; C. Saint- πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 251 KB

Twelve healthy children in three age groups anaesthetized for minor surgery were given a single oral dose of tiaprofenic acid (3 mg.kg-1) (TA). Seven blood samples and zero to 8 and 8 to 24 h urines were collected. TA concentrations in plasma and urine were measured by HPLC. No significant differenc

Pharmacokinetics of furosemide after thr
✍ Elaine S. Waller; Joseph W. Massarella; Motria Sharanevych Tomkiw; Robert V. Smi πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 396 KB πŸ‘ 2 views

Furosemide solution was orally administered to 21 healthy adult males to determine dose proportionality over the dose range used and the reproducibility of disposition following a repeated dose. Furosemide solution was given in doses of 20,40, and 80mg, with the 40 mg dose repeated once. Blood was c

Clinical pharmacokinetics of procaterol:
✍ Dr Michael A. Eldon; Debbie S. Blake; Michael J. Coon; Gerald D. Nordblom; Allen πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 328 KB πŸ‘ 2 views

Procaterol is a potent, orally active &-agonist bronchodilator useful in the treatment of reversible bronchospastic disease. It is effective when administered as single or multiple (Q8H) 50 and 75pg doses. As part of the clinical development of procaterol, the pharmacokinetics and dose proportionali